Predictive Oncology Inc. (POAI)
0.94
-0.01 (-0.90%)
At close: Apr 17, 2025, 3:59 PM
0.93
-0.99%
Pre-market: Apr 21, 2025, 06:18 AM EDT
Predictive Oncology Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|
| Pittsburgh Revenue | 3.91K | 67.25K | 4.86K | 51.03K | 417.1K | 13.84K | 10.63K |
| Pittsburgh Revenue Growth | -94.19% | +1284.42% | -90.48% | -87.77% | +2912.83% | +30.27% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2019 |
|---|---|
| Domestic Revenue | 1.28M |
| Domestic Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.83M | 3.15M | 4.31M | 3.34M | 2.92M | 3.13M | 2.71M | 3.5M | 3.62M | 2.62M | 2.73M | 3.85M | 2.23M | 2.24M | 3.39M | 2.15M | 2.35M | 3.34M | 3.09M | 2.59M | 3.05M | 4M | 2.05M | 2.56M | 1.38M | 1.66M | 2.05M | 3.6M | 923.39K | 2.45M | 1.28M | 609.79K | 870.86K | 2.37M | 2.19M | 2.35M | 1.13M | 1.15M | 127.48K |
| Selling, General, and Administrative Revenue Growth | -41.94% | -26.83% | +29.12% | +14.23% | -6.83% | +15.79% | -22.62% | -3.42% | +38.07% | -3.86% | -29.12% | +72.27% | -0.15% | -33.90% | +57.38% | -8.39% | -29.80% | +8.15% | +19.20% | -14.98% | -23.61% | +94.69% | -19.89% | +85.09% | -16.75% | -19.07% | -43.01% | +290.36% | -62.25% | +91.16% | +109.83% | -29.98% | -63.18% | +8.12% | -6.74% | +107.44% | -1.39% | +799.41% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 99.46K | 20.67K | 29.37K | 38.8K | 203.56K | 15.15K | 33.39K | 68.22K | 81.49K | 91.03K | 49.69K | 93.63K | 713.07K | 568.77K | 521.12K | 548.75K | 514.89K | 707.41K | 1.27M | 466.57K | 526.26K | 723.94K | 378.91K | n/a | 289K | n/a | n/a | 84.47K | 103.67K | 79.94K | 100.23K | 122.16K | 81.26K | 58.79K | 58.28K | 62.66K |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | +381.17% | -29.61% | -24.32% | -80.94% | +1243.52% | -54.63% | -51.05% | -16.29% | -10.48% | +83.19% | -46.93% | -86.87% | +25.37% | +9.14% | -5.04% | +6.58% | -27.21% | -44.35% | +172.47% | -11.34% | -27.31% | +91.06% | n/a | -100.00% | n/a | n/a | -100.00% | -18.52% | +29.69% | -20.25% | -17.95% | +50.33% | +38.22% | +0.87% | -6.98% | n/a |
| Sales and Marketing Revenue | 246.65K | 284.42K | 739.73K | 375.48K | 336.04K | 429.1K | 370.24K | 450.04K | 333.38K | 271.02K | 304.47K | 327.23K | 172.87K | 159.79K | 114.64K | 66K | 121.51K | 133.01K | 264.41K | 238.7K | 434.95K | 685.03K | 554.22K | 643.07K | 621.47K | 554.08K | 550.54K | 323.78K | 301.67K | 231.27K | 147.45K | 119.12K | 137.78K | 102.62K | 108.45K | 64.29K | 66.72K | 139.03K | 233.96K |
| Sales and Marketing Revenue Growth | -13.28% | -61.55% | +97.01% | +11.74% | -21.69% | +15.90% | -17.73% | +34.99% | +23.01% | -10.98% | -6.96% | +89.29% | +8.19% | +39.38% | +73.70% | -45.69% | -8.65% | -49.69% | +10.77% | -45.12% | -36.51% | +23.60% | -13.82% | +3.48% | +12.16% | +0.64% | +70.04% | +7.33% | +30.44% | +56.84% | +23.78% | -13.54% | +34.27% | -5.38% | +68.70% | -3.65% | -52.01% | -40.58% | n/a |